At Tuesday’s closing price, Mankind Pharma was valued at a price-to-earnings ratio of 43 times its FY22 earnings. Mankind is now India’s fifth largest pharma company by market value of ₹57,046 crore. Sun Pharma, Divi’s Lab, Dr. Reddy’s Lab, and Cipla are currently valued between ₹75,284 crore and ₹2.31 lakh crore.
Debt, equity holders approve merger of IDFC with IDFC First Bank
“We wish to inform that the resolution approving the Scheme was passed by the overwhelming majority of 99.95 per cent of the equity shareholders, representing